Brian  Baranick net worth and biography

Brian Baranick Biography and Net Worth

Insider of Exact Sciences
Brian Baranick serves as our General Manager, Precision Oncology. He previously served as Senior Vice President Strategy and Business Development since February 2021 and Vice President, Strategy & Internal Consulting. Prior to joining Exact Sciences, Mr. Baranick was with L.E.K. Consulting, LLC., where he was a Partner and Managing Director focused on growing the diagnostics and life science tools segment of L.E.K.’s healthcare vertical. Mr. Baranick holds a Ph.D. in Molecular Biology from the University of California Los Angeles.

What is Brian Baranick's net worth?

The estimated net worth of Brian Baranick is at least $757,825.20 as of October 8th, 2024. Mr. Baranick owns 12,758 shares of Exact Sciences stock worth more than $757,825 as of December 21st. This net worth estimate does not reflect any other investments that Mr. Baranick may own. Additionally, Mr. Baranick receives a salary of $942,890.00 as Insider at Exact Sciences. Learn More about Brian Baranick's net worth.

How old is Brian Baranick?

Mr. Baranick is currently 46 years old. There are 6 older executives and no younger executives at Exact Sciences. The oldest executive at Exact Sciences is Mr. Kevin T. Conroy, Chairman of The Board & CEO, who is 58 years old. Learn More on Brian Baranick's age.

What is Brian Baranick's salary?

As the Insider of Exact Sciences Co., Mr. Baranick earns $942,890.00 per year. There are 2 executives that earn more than Mr. Baranick. The highest earning executive at Exact Sciences is Mr. Kevin T. Conroy, Chairman of The Board & CEO, who commands a salary of $3,140,000.00 per year. Learn More on Brian Baranick's salary.

How do I contact Brian Baranick?

The corporate mailing address for Mr. Baranick and other Exact Sciences executives is 5505 ENDEAVOR LANE, MADISON WI, 53719. Exact Sciences can also be reached via phone at (608) 284-5700 and via email at [email protected]. Learn More on Brian Baranick's contact information.

Has Brian Baranick been buying or selling shares of Exact Sciences?

During the last ninety days, Brian Baranick has sold $65,030.00 in shares of Exact Sciences stock. Most recently, Brian Baranick sold 929 shares of the business's stock in a transaction on Tuesday, October 8th. The shares were sold at an average price of $70.00, for a transaction totalling $65,030.00. Following the completion of the sale, the executive vice president now directly owns 12,758 shares of the company's stock, valued at $893,060. Learn More on Brian Baranick's trading history.

Who are Exact Sciences' active insiders?

Exact Sciences' insider roster includes Brian Baranick (Insider), Sarah Condella (SVP), Kevin Conroy (CEO), D. Coward (Insider), Everett Cunningham (Insider), James Doyle (Director), Jeffrey Elliott (CFO), James Herriott (General Counsel), Torsten Hoof (Insider), Daniel Levangie (Director), Graham Lidgard (Insider), Jacob Orville (Insider), and Katherine Zanotti (Director). Learn More on Exact Sciences' active insiders.

Are insiders buying or selling shares of Exact Sciences?

In the last twelve months, Exact Sciences insiders bought shares 1 times. They purchased a total of 19,500 shares worth more than $1,001,325.00. In the last twelve months, insiders at the medical research company sold shares 35 times. They sold a total of 75,348 shares worth more than $4,597,043.93. The most recent insider tranaction occured on November, 13th when CEO Kevin T Conroy bought 19,500 shares worth more than $1,001,325.00. Insiders at Exact Sciences own 1.4% of the company. Learn More about insider trades at Exact Sciences.

Information on this page was last updated on 11/13/2024.

Brian Baranick Insider Trading History at Exact Sciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/8/2024Sell929$70.00$65,030.0012,758View SEC Filing Icon  
9/18/2024Sell929$70.00$65,030.0013,687View SEC Filing Icon  
5/1/2024Sell110$60.15$6,616.5013,279View SEC Filing Icon  
1/2/2024Sell879$73.50$64,606.507,992View SEC Filing Icon  
8/7/2023Sell1,350$85.04$114,804.008,871View SEC Filing Icon  
See Full Table

Brian Baranick Buying and Selling Activity at Exact Sciences

This chart shows Brian Baranick's buying and selling at Exact Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Exact Sciences Company Overview

Exact Sciences logo
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Read More

Today's Range

Now: $59.40
Low: $55.98
High: $59.70

50 Day Range

MA: $61.91
Low: $49.33
High: $71.93

2 Week Range

Now: $59.40
Low: $40.62
High: $79.62

Volume

3,273,828 shs

Average Volume

2,615,913 shs

Market Capitalization

$10.99 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24